Developing next-generation and breakthrough biologics can be a painstakingly slow process. However, harnessing new and emerging technology, like AI, can help speed this process and provide first-to-market capability. In a competitive industry like biologics, being first is everything.
Join us on this fascinating panel as we learn from some of the leading innovators and tech-focused experts from the biologics and pharma space as they discuss introducing improved technology and address some of the more vexing problems in the winding road of discovery to launch. This panel will highlight how just having solutions isn’t enough. Being able to implement change and streamline workflows are just part of the conversation.
In this session you’ll learn:- Ways to build infrastructure for introducing new technology
- Develop metrics and analysis to uncover ROI
- Address the risks and ethics associated with AI
